DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Imagawa T, Yokota S, Mori M et al.
Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis.
Mod Rheumatol 2011; Epub ahead of print
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.